Alphabet unveiled Verily Study Watch in 2017, describing it as a smartwatch designed specifically for capturing health data from clinical study participants.
Alphabet unveiled Verily Study Watch in 2017, describing it as a smartwatch designed specifically for capturing health data from clinical study participants. The watch has been put to good use in the months since its launch, including in studies involving Parkinson’s disease. The wearable features an on-demand ECG device and has just earned FDA approval as a Class II medical device.
The Verily Study Watch has been cleared by the FDA as a medical device that can record, store, transfer, and display ECG data, the company announced today.
